Pain After Endoscopic Submucosal Dissection

Status Completed

Clinical Trial Summary

Endoscopic submucosal dissection (ESD) is widely used for local treatment of gastric neoplasms. Although ESD-related complications such as bleeding and perforation have been reported, data is currently lacking on the development of pain, which is one of the most common adverse events after ESD. Therefore, in the present study, we investigated the incidence and clinicopathologic risk factors of pain after ESD.

Clinical Trial Description

A prospective randomized controlled study was conducted evaluating 156 patients with gastric neoplasms treated by ESD at Gangnam Severance Hospital between April 2011 and December 2014. All subjects were randomly assigned to treatment with intravenous proton pump inhibitor (PPI) either before or after ESD. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02254889
Study type	Interventional
Source	Gangnam Severance Hospital
Contact
Status	Completed
Phase	N/A
Start date	April 2011
Completion date	December 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02543411` - Use of Lidocaine in Endoscopic Submucosal Dissection	N/A
Completed	`NCT02128243` - Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer	Phase 2
Active, not recruiting	`NCT00506207` - A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy	Phase 1
Completed	`NCT04830618` - Aberrant DNA Methylation to Predict Metachronous Gastric Neoplasms
Completed	`NCT02235246` - The Effect of Perioperative Intravenous Magnesium on Pain After Endoscopic Submucosal Dissection for Gastric Neoplasm: Prospective Randomized Double-blind Placebo Controlled Study	Phase 4
Completed	`NCT00252161` - A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer	Phase 3
Recruiting	`NCT04622098` - Prevalence of Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt
Terminated	`NCT01870791` - Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer	Phase 2
Completed	`NCT03255070` - A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)	Phase 1
Recruiting	`NCT06342427` - Stomach Cancer Exosome-based Detection
Recruiting	`NCT04780256` - Endoscopic Resection of Gastrointestinal Neoplasms
Recruiting	`NCT03065257` - Endoscopic Resection Multicenter Registry	N/A
Recruiting	`NCT05804331` - The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study
Completed	`NCT05265221` - Learning Curve for Gastric Endoscopic Submucosal Dissection
Recruiting	`NCT03597581` - A Study of RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer	Phase 1
Completed	`NCT00112099` - GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110	Phase 3
Recruiting	`NCT04466631` - Health and Employment After Gastro Intestinal Surgery - HEAGIS2
Terminated	`NCT00149266` - Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)	Phase 3
Completed	`NCT00149279` - A Trial to Evaluate Para-aortic Lymphadenectomy for Gastric Cancer	Phase 3
Recruiting	`NCT06362070` - Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Gastrectomy	N/A